Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 04 Aug 2021 |
2 | Reply to Exam Report (MIS-R) | 20 Sep 2021 |
3 | TM-M(EXTENSION OF TIME) | 26 Dec 2023 |
4 | Authorization Letter | 20 Feb 2024 |
5 | TM-M(EXTENSION OF TIME) | 21 Feb 2024 |
6 | TM-O(NOTICE OF OPPOSITION) | 27 Jun 2024 |
7 | Journal Copy | 09 Jul 2024 |
1 | EXAMINATION REPORT | 11999737 | 14 Aug 2021 | |
2 | Hearing Notice (Show Cause) | 16552715 | 16 Nov 2023 | |
3 | Hearing Notice (Show Cause) | 17127666 | 12 Jan 2024 | |
4 | Tribunal Accepted Notice for : 5075976 | 17659894 | 6617112 | 08 Mar 2024 |
5 | Opposition Notice | 18543114 | 6822612 | 22 Jul 2024 |
6 | Opposition Counter Statement | 19007355 | 6942819 | 16 Oct 2024 |
Trademark was applied on 04 August 2021 with IP India.
Proprietor of Cpodxime is AKUMS DRUGS PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 5.
Status of Cpodxime is Opposed.
Application number alloted to the trademark is 5075976.
Trademark has been filed in the following category:
WORD